Comment on Ferrannini et al. CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis. Diabetes Care 2016;39:1108-1114

Jens Jordan, Ali El-Armouche, Markolf Hanefeld, Stefan R Bornstein, Andreas L Birkenfeld

Research output: Contribution to journalLetterpeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)e224-e225
JournalDiabetes Care
Volume39
Issue number12
DOIs
Publication statusPublished - Dec 2016

Keywords

  • Humans
  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2

Cite this